Navigation Links
LCA Hails International Investigators Studying Lung Cancer
Date:9/4/2007

Recommendations to Help Doctors and Patients More Precisely Stage, Diagnose

and Treat Lung Cancer

SEOUL, South Korea, Sept. 4 /PRNewswire-USNewswire/ -- Lung Cancer Alliance (LCA), the only US-based organization devoted exclusively to patient support and advocacy for those living with or at risk for lung cancer, hailed today's presentation by lead investigators of the International Association for the Study of Lung Cancer (IASLC) at the 12th World Conference on Lung Cancer (WCLC), as a significant development in how doctors and patients will more precisely stage, diagnose and treat lung cancer.

Every seven years international staging guidelines undergo a reevaluation to determine whether changes need to be made to the staging classification system. This is important because precise staging will provide clinicians with a common basis for the selection of the clinical management to minimize possible side effects while optimizing the chance of a favorable outcome for patients.

The IASLC study, which collected data on more than 100,000 patients worldwide, confirmed that in the last decade improvements in understanding tumor characteristics, emergence of new anti-cancer therapy and advancements in technology, particularly CT and PET scans, have allowed for a more precise analysis of tumor (T), lymph node (N) and metastasis (M) descriptors that make up the lung cancer staging system.

"Patients diagnosed with lung cancer will now benefit from a more accurate assessment of their disease, its staging and treatment protocols", said Laurie Fenton Ambrose, President of Lung Cancer Alliance. "By continuing to refine our knowledge -- we will more positively impact patient outcomes. I applaud IASLC for significant contribution in this area."

The IASLC study recommendations are due to be implemented in 2009 upon publication by the International Union Against Cancer and the American Joint Committee on Cancer.

Patients will not be negatively impacted by this reclassification.

Lung Cancer Alliance (http://www.LungCancerAlliance.org) is the only national non-profit organization solely dedicated to patient support and advocacy for people living with, or at risk for, lung cancer. As the number one cancer killer, lung cancer will kill more than 160,000 Americans and 1 million people worldwide this year alone.


'/>"/>
SOURCE Lung Cancer Alliance
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. LCA Hails Congressional Front Against Pink Camel Cigarette Campaign
2. PETA Hails McCartney for Boycotting Animal-testing Charities
3. International community warns India on HIV situation
4. Key step forward on International Health Rules
5. ICMR along with other International Research organisation with drug development for Neglected Diseases
6. International Osteoporosis Research Centre To Be Started In India.
7. Indian hospitals require International Accreditation
8. International Conference On Malaria - Laveran To Genomics
9. Delhi To Host International Women’s Congress From Nov 2
10. International conference on Ayurveda to be held on Kerala
11. International Teleradiology: The Future Of Radiologic Diagnosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... , ... Cellairis is a worldwide mobile device and computer repair franchise that ... and Samsung Galaxy devices with premium parts and accessories. Cellairis has recently set-up ... accessibility for customers. While customers do their shopping, Cellairis can accomplish a number of ...
(Date:12/9/2016)... ... ... An inventor from Cana, Va., wanted to fulfill the need for a ... , The patent-pending SAFETY STRAP FOR AMPUTEES improves accessibility. It eliminates discrimination. It is ... in a matter of minutes, or even seconds. The SAFETY STRAP FOR AMPUTEES is ...
(Date:12/9/2016)... ... 09, 2016 , ... The Pennsylvania Athletic Trainers’ Society (PATS) ... summer of 2016. The program was made possible by a Pennsylvania Department of ... Health and Human Services Administration. The broadcast, Use Your Head: Properly Managing ...
(Date:12/8/2016)... Islandia, NY (PRWEB) , ... December 08, 2016 ... ... company, is pleased to announce that “Natural Language Processing–Enabled and Conventional Data Capture ... published in JMIR Medical Informatics . , Results of the comparative usability ...
(Date:12/8/2016)... Boston (PRWEB) , ... December 08, 2016 , ... ... shareholders with global law firm Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. ... sponsor of the DeviceTalks series, and attorneys from the firm’s global Life Sciences & ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... Research and Markets has announced the addition of the "Endodontic Supplies ... ... the worldwide markets for Endodontic Supplies in US$ Thousand. The report provides separate ... , Europe , Asia-Pacific , ... and forecasts are provided for the period 2015 through 2022. Also, a six-year ...
(Date:12/8/2016)... Dec. 8, 2016   TriNetX , the ... Children,s Hospital signed a membership agreement to ... development of new cures. The TriNetX ... 57 million patients globally, biopharmaceutical companies and contract ... improve protocol design, site selection, patient recruitment, and ...
(Date:12/8/2016)... 2016  Valeant Pharmaceuticals International, Inc. (NYSE: ... announced positive results from a Phase 3, multicenter ... safety and efficacy of IDP-118 (halobetasol propionate and ... Within the Phase 3 study ... psoriasis, IDP-118 showed statistical significance to vehicle with ...
Breaking Medicine Technology: